Fidaxomicin Interactions
There are 129 drugs known to interact with fidaxomicin. Of the total drug interactions, 3 are major, 63 are moderate, and 63 are minor.
- View all 129 medications that may interact with fidaxomicin
Most frequently checked interactions
View interaction reports for fidaxomicin and the medicines listed below.
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aleve (naproxen)
- Augmentin (amoxicillin / clavulanate)
- Bumex (bumetanide)
- Carafate (sucralfate)
- Cipro (ciprofloxacin)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Colace (docusate)
- Compazine (prochlorperazine)
- CoQ10 (ubiquinone)
- Coreg (carvedilol)
- Crestor (rosuvastatin)
- Eliquis (apixaban)
- Flagyl (metronidazole)
- Flonase (fluticasone nasal)
- Heparin Sodium (heparin)
- Metoprolol Succinate ER (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Phenergan (promethazine)
- Plavix (clopidogrel)
- Protonix (pantoprazole)
- Retinol (vitamin a topical)
- Rutin (bioflavonoids)
- Sotalol Hydrochloride AF (sotalol)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
More about fidaxomicin
- fidaxomicin consumer information
- Check interactions
- Compare alternatives
- Reviews (19)
- Side effects
- Dosage information
- During pregnancy
- Drug class: macrolides
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.